42.33
price up icon0.57%   0.24
pre-market  プレマーケット:  42.58   0.25   +0.59%
loading

Qiagen Nv (QGEN) 最新ニュース

pulisher
05:46 AM

Reasons to Retain QIAGEN Stock in Your Portfolio for Now - Yahoo Finance

05:46 AM
pulisher
02:27 AM

Gene Panel Market to Surpass USD 11.75 Billion by 2031 | SkyQuest Technology - GlobeNewswire Inc.

02:27 AM
pulisher
Nov 21, 2024

Massachusetts Financial Services Co. MA Sells 79,145 Shares of Qiagen (NYSE:QGEN) - MarketBeat

Nov 21, 2024
pulisher
Nov 21, 2024

Jennison Associates LLC Boosts Position in Qiagen (NYSE:QGEN) - MarketBeat

Nov 21, 2024
pulisher
Nov 20, 2024

QIAGEN NV : Jefferies is Neutral - Marketscreener.com

Nov 20, 2024
pulisher
Nov 20, 2024

Qiagen (NYSE:QGEN) Stake Lowered by Nuance Investments LLC - MarketBeat

Nov 20, 2024
pulisher
Nov 20, 2024

QIAGEN Stock Flat Post Q3 Earnings & Revenue Beat, 2024 EPS View Up - MSN

Nov 20, 2024
pulisher
Nov 20, 2024

Qiagen (NYSE:QGEN) Receives Consensus Rating of "Moderate Buy" from Brokerages - MarketBeat

Nov 20, 2024
pulisher
Nov 18, 2024

Qiagen (NYSE:QGEN) Shares Bought by Natixis Advisors LLC - MarketBeat

Nov 18, 2024
pulisher
Nov 16, 2024

180,729 Shares in Qiagen (NYSE:QGEN) Purchased by Impax Asset Management Group plc - MarketBeat

Nov 16, 2024
pulisher
Nov 13, 2024

QGEN Collaborates With McGill University Centre: Stock to Gain? - Yahoo Finance

Nov 13, 2024
pulisher
Nov 13, 2024

Victory Capital Management Inc. Has $117.33 Million Stock Position in Qiagen (NYSE:QGEN) - MarketBeat

Nov 13, 2024
pulisher
Nov 13, 2024

What is William Blair's Estimate for Qiagen FY2024 Earnings? - MarketBeat

Nov 13, 2024
pulisher
Nov 13, 2024

Crossmark Global Holdings Inc. Sells 12,133 Shares of Qiagen (NYSE:QGEN) - MarketBeat

Nov 13, 2024
pulisher
Nov 13, 2024

Pharmahungary Group participates in ambitious EU EVEREST Project - European Biotechnology News

Nov 13, 2024
pulisher
Nov 12, 2024

QIAGEN collaborates with McGill University to advance microbiome research - GlobeNewswire

Nov 12, 2024
pulisher
Nov 12, 2024

QIAGEN Partners with McGill to Target $1.8B Microbiome Market in Major Research Deal | QGEN Stock News - StockTitan

Nov 12, 2024
pulisher
Nov 11, 2024

Don't Overlook Qiagen (QGEN) International Revenue Trends While Assessing the Stock - Yahoo Finance

Nov 11, 2024
pulisher
Nov 11, 2024

QIAGEN NV : UBS reiterates its Neutral rating - Marketscreener.com

Nov 11, 2024
pulisher
Nov 09, 2024

Earnings call: QIAGEN tops Q3 expectations, raises 2024 EPS outlook - Investing.com India

Nov 09, 2024
pulisher
Nov 08, 2024

Earnings call: QIAGEN tops Q3 expectations, raises 2024 EPS outlook By Investing.com - Investing.com Australia

Nov 08, 2024
pulisher
Nov 08, 2024

Qiagen Non-GAAP EPS of $0.46 beats by $0.02, revenue of $459M beats by $2.09M - MSN

Nov 08, 2024
pulisher
Nov 08, 2024

Wellington Management Group LLP's Strategic Acquisition of Qiage - GuruFocus.com

Nov 08, 2024
pulisher
Nov 08, 2024

Why Qiagen (QGEN) is a Top Value Stock for the Long-Term - Yahoo Finance

Nov 08, 2024
pulisher
Nov 08, 2024

Qiagen NV (QGEN) Q3 2024 Earnings Call Highlights: Strong Revenue Growth and Strategic Advancements - GuruFocus.com

Nov 08, 2024
pulisher
Nov 07, 2024

Qiagen Reports Strong Q3 2024 Growth - TipRanks

Nov 07, 2024
pulisher
Nov 07, 2024

Is There An Opportunity With Qiagen N.V.'s (NYSE:QGEN) 31% Undervaluation? - Yahoo Finance

Nov 07, 2024
pulisher
Nov 07, 2024

QIAGEN NV : Deutsche Bank reaffirms its Buy rating - Marketscreener.com

Nov 07, 2024
pulisher
Nov 07, 2024

Qiagen Q3 24 Earnings Conference Call At 9:30 AM ET - Nasdaq

Nov 07, 2024
pulisher
Nov 07, 2024

QIAGEN : Markets hailed the Q3 beat + the profitability upgrade - Marketscreener.com

Nov 07, 2024
pulisher
Nov 07, 2024

QIAGEN NV : Receives a Buy rating from Berenberg - Marketscreener.com

Nov 07, 2024
pulisher
Nov 07, 2024

Qiagen (NYSE:QGEN) Shares Sold by Van ECK Associates Corp - MarketBeat

Nov 07, 2024
pulisher
Nov 07, 2024

Qiagen N : QIAGEN delivers solid Q3 2024 growth ahead of outlook, increases full year 2024 adjusted EPS outlook - Marketscreener.com

Nov 07, 2024
pulisher
Nov 07, 2024

QIAGEN NV : UBS reaffirms its Neutral rating - Marketscreener.com

Nov 07, 2024
pulisher
Nov 06, 2024

Qiagen N.V. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2024 - Marketscreener.com

Nov 06, 2024
pulisher
Nov 06, 2024

Compared to Estimates, Qiagen (QGEN) Q3 Earnings: A Look at Key Metrics - Yahoo Finance

Nov 06, 2024
pulisher
Nov 06, 2024

Qiagen (QGEN) Q3 Earnings and Revenues Top Estimates - Yahoo Finance

Nov 06, 2024
pulisher
Nov 06, 2024

Diagnostics firm Qiagen reports rise in third-quarter revenue - Reuters

Nov 06, 2024
pulisher
Nov 06, 2024

QIAGEN delivers solid Q3 2024 growth ahead of outlook, increases full-year 2024 adjusted EPS outlook - The Manila Times

Nov 06, 2024
pulisher
Nov 06, 2024

QIAGEN Q3 Earnings Surge: Sales Hit $502M, Boosts 2024 EPS Outlook | QGEN Stock News - StockTitan

Nov 06, 2024
pulisher
Nov 06, 2024

Qiagen NV (QGEN) Q3 2024: Everything You Need to Know Ahead of E - GuruFocus.com

Nov 06, 2024
pulisher
Nov 05, 2024

FDA clears fourth Qiagen test in 2024 - BioWorld Online

Nov 05, 2024
pulisher
Nov 05, 2024

Qiagen NV (QGEN) Q3 2024 Earnings Report Preview: What to Expect - GuruFocus.com

Nov 05, 2024
pulisher
Nov 04, 2024

QGEN Stock Set to Gain From FDA's Clearance of QIAstat-Dx Mini Panel - Yahoo Finance

Nov 04, 2024
pulisher
Nov 04, 2024

Qiagen (QGEN) Q3 Earnings Preview: What You Should Know Beyond the Headline Estimates - Yahoo Finance

Nov 04, 2024
pulisher
Nov 04, 2024

QIAGEN receives FDA clearance of QIAstat-Dx meningitis/encephalitis panel to support emergency diagnostics - GlobeNewswire

Nov 04, 2024
pulisher
Nov 04, 2024

Qiagen Receives FDA Clearance Of Qiastat-Dx Meningitis/Encephalitis Panel To Support Emergency Diagnostics - XM

Nov 04, 2024
pulisher
Oct 31, 2024

Forsta AP Fonden Sells 18,586 Shares of Qiagen (NYSE:QGEN) - MarketBeat

Oct 31, 2024
pulisher
Oct 30, 2024

Qiagen (QGEN) Set to Announce Earnings on Wednesday - MarketBeat

Oct 30, 2024
pulisher
Oct 30, 2024

Raymond James & Associates Trims Position in Qiagen (NYSE:QGEN) - MarketBeat

Oct 30, 2024
diagnostics_research LH
$240.17
price up icon 0.98%
$169.36
price up icon 0.88%
$136.99
price up icon 4.03%
diagnostics_research WAT
$368.50
price up icon 3.00%
diagnostics_research MTD
$1,196.82
price up icon 2.56%
$418.55
price down icon 0.01%
大文字化:     |  ボリューム (24 時間):